Literature DB >> 15001479

Treating malaria in Africa.

Brian Greenwood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15001479      PMCID： PMC381032          DOI： 10.1136/bmj.328.7439.534

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

1.  Antifolate antimalarial resistance in southeast Africa: a population-based analysis.

Authors:  Cally Roper; Richard Pearce; Barry Bredenkamp; Jonathan Gumede; Chris Drakeley; Frank Mosha; Daniel Chandramohan; Brian Sharp
Journal:  Lancet       Date:  2003-04-05       Impact factor: 79.321

2.  Chloroquine-resistant falciparum malaria from Africa.

Authors:  B H Kean
Journal:  JAMA       Date:  1979-01-26       Impact factor: 56.272

3.  Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania.

Authors:  T Mutabingwa; A Nzila; E Mberu; E Nduati; P Winstanley; E Hills; W Watkins
Journal:  Lancet       Date:  2001-10-13       Impact factor: 79.321

Review 4.  Epidemiology of drug-resistant malaria.

Authors:  Chansuda Wongsrichanalai; Amy L Pickard; Walther H Wernsdorfer; Steven R Meshnick
Journal:  Lancet Infect Dis       Date:  2002-04       Impact factor: 25.071

5.  The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy.

Authors: 
Journal:  Trop Med Int Health       Date:  2003-10       Impact factor: 2.622

Review 6.  Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy.

Authors:  Eline L Korenromp; Brian G Williams; Eleanor Gouws; Christopher Dye; Robert W Snow
Journal:  Lancet Infect Dis       Date:  2003-06       Impact factor: 25.071

Review 7.  Combination therapy for malaria: the way forward?

Authors:  François Nosten; Philippe Brasseur
Journal:  Drugs       Date:  2002       Impact factor: 9.546

8.  Chloroquine-resistant Plasmodium falciparum malaria in Kenya.

Authors:  S Fogh; S Jepsen; P Effersøe
Journal:  Trans R Soc Trop Med Hyg       Date:  1979       Impact factor: 2.184

9.  Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study.

Authors:  Christopher V Plowe; James G Kublin; Fraction K Dzinjalamala; Deborah S Kamwendo; Rabia A G Mukadam; Phillips Chimpeni; Malcolm E Molyneux; Terrie E Taylor
Journal:  BMJ       Date:  2004-02-02

10.  Impact of chloroquine resistance on malaria mortality.

Authors:  J F Trape; G Pison; M P Preziosi; C Enel; A Desgrées du Loû; V Delaunay; B Samb; E Lagarde; J F Molez; F Simondon
Journal:  C R Acad Sci III       Date:  1998-08
View more
  2 in total

1.  Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria.

Authors:  Sunny Oyakhirome; Saadou Issifou; Peter Pongratz; Fortune Barondi; Michael Ramharter; Jürgen F Kun; Michel A Missinou; Bertrand Lell; Peter G Kremsner
Journal:  Antimicrob Agents Chemother       Date:  2007-02-26       Impact factor: 5.191

2.  Efficacy of pyrimethamine-sulfadoxine in young children with uncomplicated falciparum malaria in rural Burkina Faso.

Authors:  Olaf Müller; Corneille Traore; Bocar Kouyate
Journal:  Malar J       Date:  2004-05-11       Impact factor: 2.979
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.